New York-based Health Catalyst Capital Management (HCCM) made the investment, joining Oxeon Venture Studios.
The company intends to use the funds to scale its program nationwide and drive platform enhancements.
Led by Daniel Pizzarello, MD, Founder and CEO, Risalto is a tech and data enabled healthcare services company which provides a platform connecting patients, employers, and providers to musculoskeletal care through proprietary algorithms and delivering personalized solutions for patients with low back, neck, and joint pain.
According to a written release, Risalto has shown to improve pain scores up to 50% in participating members and has a 95% success rate in influencing members’ choice in care.
FinSMEs
13/11/2019